EUVIMEDEUVIMED entdecken
Open Access

Notes from the Field : Mpox Cluster Caused by Tecovirimat-Resistant Monkeypox Virus — Five States, October 2023–February 2024

Crystal M Gigante, Jade Takakuwa, Daisy McGrath, Chantal Kling, Todd G Smith, Mengfei Peng, Kimberly Wilkins, Jacob M Garrigues, Taylor Holly, Hannah Barbian, Alyse Kittner, Danielle Haydel und 17 weitere

MMWR. Morbidity and Mortality Weekly Report · 2024

DOI: 10.15585/mmwr.mm7340a3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, 2024. Verfasst von Crystal M Gigante und 28 weiteren Autor:innen. Hauptthemen laut MEDLINE: Drug Resistance, Viral, Antiviral Agents, Mpox, Monkeypox, Monkeypox virus. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antiviral drug tecovirimat* has been used extensively to treat U.S. mpox cases since the start of a global outbreak in 2022. Mutations in the mpox viral protein target (F13 or VP37) that occur during treatment can result in resistance to tecovirimat† (1,2). CDC and public health partners have conducted genetic surveillance of monkeypox virus (MPXV) for F13 mutations through sequencing and monitoring of public databases. MPXV F13 mutations associated with resistance have been reported since 2022, typically among severely immunocompromised mpox patients who required prolonged courses of tecovirimat (3-5). A majority of patients with infections caused by MPXV with resistant mutations had a history of tecovirimat treatment; however, spread of tecovirimat-resistant MPXV was reported in California during late 2022 to early 2023 among persons with no previous tecovirimat treatment (3). This report describes a second, unrelated cluster of tecovirimat-resistant MPXV among 18 persons with no previous history of tecovirimat treatment in multiple states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, ViralAntiviral AgentsMpox, MonkeypoxMonkeypox virusDisease OutbreaksHumansUnited StatesAdultMaleFemaleMiddle AgedAdolescentYoung AdultAgedChildMutationDibenzothiepinsBenzamidesPhthalimides

Substanzen

Antiviral AgentstecovirimatDibenzothiepinsBenzamidesPhthalimides

Zitieren

APA

Gigante, C. M., Takakuwa, J., McGrath, D., Kling, C., Smith, T. G., Peng, M., Wilkins, K., Garrigues, J. M., Holly, T., Barbian, H., Kittner, A., Haydel, D., Ortega, E., Richardson, G., Hand, J., Hacker, J. K., Espinosa, A., Haw, M., Kath, C., …, & Hutson, C. L. (2024). Notes from the Field : Mpox Cluster Caused by Tecovirimat-Resistant Monkeypox Virus — Five States, October 2023–February 2024. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7340a3

Vancouver

Gigante CM, Takakuwa J, McGrath D, Kling C, Smith TG, Peng M, et al. Notes from the Field : Mpox Cluster Caused by Tecovirimat-Resistant Monkeypox Virus — Five States, October 2023–February 2024. MMWR. Morbidity and Mortality Weekly Report. 2024. doi:10.15585/mmwr.mm7340a3

BibTeX
@article{Gigante2024,
  author = {Gigante, Crystal M and Takakuwa, Jade and McGrath, Daisy and Kling, Chantal and Smith, Todd G and Peng, Mengfei and Wilkins, Kimberly and Garrigues, Jacob M and Holly, Taylor and Barbian, Hannah and Kittner, Alyse and Haydel, Danielle and Ortega, Emma and Richardson, Gillian and Hand, Julie and Hacker, Jill K and Espinosa, Alex and Haw, Monica and Kath, Chantha and Bielby, Meilan and Short, Kirstin and Johnson, Kimberly and De La Cruz, Nelson and Davidson, Whitni and Hughes, Christine and Green, Nicole M and Baird, Nicolle and Rao, Agam K and Hutson, Christina L},
  title = {Notes from the Field : Mpox Cluster Caused by Tecovirimat-Resistant Monkeypox Virus — Five States, October 2023–February 2024},
  journal = {MMWR. Morbidity and Mortality Weekly Report},
  year = {2024},
  doi = {10.15585/mmwr.mm7340a3}
}
Kostenlos starten →